Emanuele Di Angelantonio

Summary

Affiliation: University of Cambridge
Country: UK

Publications

  1. ncbi B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies
    Emanuele Di Angelantonio
    Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Wort s Causeway, Cambridge, England CB1 8RN
    Circulation 120:2177-87. 2009
  2. ncbi Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study
    Emanuele Di Angelantonio
    Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK
    BMJ 341:c4986. 2010
  3. ncbi Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies
    David Wormser
    Emerging Risk Factors Collaboration Coordinating Centre, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge CB1 8RN, UK
    Lancet 377:1085-95. 2011
  4. ncbi Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk
    Alexander Thompson
    Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge, England CB1 8RN
    JAMA 299:2777-88. 2008
  5. ncbi Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants
    Sebhat Erqou
    Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
    J Am Coll Cardiol 55:2160-7. 2010
  6. ncbi Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies
    Alexander Thompson
    Lp PLA2 Studies Collaboration Coordinating Centre, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge CB1 8RN, UK
    Lancet 375:1536-44. 2010
  7. ncbi Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
    Nadeem Sarwar
    Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Wort s Causeway, Cambridge CB1 8RN, UK
    Lancet 375:1634-9. 2010
  8. ncbi Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data
    Anna Bennet
    Department of Public Health and Primary Care, University of Cambridge, Cambridge, England
    Arch Intern Med 168:598-608. 2008
  9. ncbi C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
    Stephen Kaptoge
    Emerging Risk Factors Collaboration Coordinating Centre, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge CB1 8RN, UK
    Lancet 375:132-40. 2010
  10. ncbi Markers of inflammation and risk of coronary heart disease
    Nadeem Sarwar
    Section of Population Health, University of Aberdeen, UK Department of Public Health and Primary Care, University of Cambridge, UK
    Dis Markers 26:217-25. 2009

Collaborators

Detail Information

Publications13

  1. ncbi B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies
    Emanuele Di Angelantonio
    Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Wort s Causeway, Cambridge, England CB1 8RN
    Circulation 120:2177-87. 2009
    ....
  2. ncbi Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study
    Emanuele Di Angelantonio
    Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK
    BMJ 341:c4986. 2010
    ..To quantify associations of chronic kidney disease stages with major cardiovascular disease and non-vascular mortality in the general adult population...
  3. ncbi Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies
    David Wormser
    Emerging Risk Factors Collaboration Coordinating Centre, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge CB1 8RN, UK
    Lancet 377:1085-95. 2011
    ..We studied the separate and combined associations of body-mass index (BMI), waist circumference, and waist-to-hip ratio with risk of first-onset cardiovascular disease...
  4. ncbi Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk
    Alexander Thompson
    Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge, England CB1 8RN
    JAMA 299:2777-88. 2008
    ..The importance of the cholesteryl ester transfer protein (CETP) pathway in coronary disease is uncertain. Study of CETP genotypes can help better understand the relevance of this pathway to lipid metabolism and disease risk...
  5. ncbi Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants
    Sebhat Erqou
    Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
    J Am Coll Cardiol 55:2160-7. 2010
    ..The purpose of this study was to assess the association of apolipoprotein(a) (apo[a]) isoforms with cardiovascular disease risk...
  6. ncbi Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies
    Alexander Thompson
    Lp PLA2 Studies Collaboration Coordinating Centre, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge CB1 8RN, UK
    Lancet 375:1536-44. 2010
    ..We investigated associations of circulating Lp-PLA(2) mass and activity with risk of coronary heart disease, stroke, and mortality under different circumstances...
  7. ncbi Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
    Nadeem Sarwar
    Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Wort s Causeway, Cambridge CB1 8RN, UK
    Lancet 375:1634-9. 2010
    ..Whether triglyceride-mediated pathways are causally relevant to coronary heart disease is uncertain. We studied a genetic variant that regulates triglyceride concentration to help judge likelihood of causality...
  8. ncbi Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data
    Anna Bennet
    Department of Public Health and Primary Care, University of Cambridge, Cambridge, England
    Arch Intern Med 168:598-608. 2008
    ....
  9. ncbi C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
    Stephen Kaptoge
    Emerging Risk Factors Collaboration Coordinating Centre, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge CB1 8RN, UK
    Lancet 375:132-40. 2010
    ..We assessed the associations of CRP concentration with risk of vascular and non-vascular outcomes under different circumstances...
  10. ncbi Markers of inflammation and risk of coronary heart disease
    Nadeem Sarwar
    Section of Population Health, University of Aberdeen, UK Department of Public Health and Primary Care, University of Cambridge, UK
    Dis Markers 26:217-25. 2009
    ....
  11. ncbi Renal function and risk of coronary heart disease in general populations: new prospective study and systematic review
    Emanuele Di Angelantonio
    Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
    PLoS Med 4:e270. 2007
    ..This study aims to quantify the association of markers of renal function with CHD risk in essentially general populations...
  12. ncbi Association of apolipoprotein E genotypes with lipid levels and coronary risk
    Anna M Bennet
    Department of Public Health and Primary Care, University of Cambridge, Cambridge, England
    JAMA 298:1300-11. 2007
    ..Previous reviews of associations of apolipoprotein E (apoE) genotype and coronary disease have been dominated by smaller studies that are liable to biases...
  13. ncbi Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis
    Adriana Buitrago-Lopez
    Department of Public Health and Primary Care, Cardiovascular Epidemiology Unit, University of Cambridge, Strangeways Research Laboratory, Cambridge CB1 8RN, UK
    BMJ 343:d4488. 2011
    ..To evaluate the association of chocolate consumption with the risk of developing cardiometabolic disorders...